Home › Overweight › Kentucky › Lexington
Overweight clinical trials in Lexington, KY
6 studies for Overweight are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RecruitingPhase 2
- AMR Clinical - Lexington, Lexington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- AMR Clinical, Lexington
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
RecruitingPhase 1
- The Alliance for Multispecialty Research - Lexington, Lexington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
RecruitingPhase 3
- The Alliance for Multispecialty Research LLC AMR, Lexington
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
RecruitingObservational study
- University of Kentucky, Lexington
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
RecruitingPhase 1
- MBX Biosciences Investigational Site, Lexington
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Miami, FL23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Ovarian Cancer15 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer12 studies
- Obesity12 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer10 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Heart Failure9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.